Colin Hill - 08 Dec 2021 Form 4 Insider Report for PPD, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 08 Dec 2021
Net transaction value: -$775,675
SEC form: 4
Accepted by SEC: 08 Dec 2021, 15:41:24 UTC
Next SEC filing: 18 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Richard Whitlow, as Attorney-in-Fact

Key filing fact

Colin Hill filed Form 4 for PPD, Inc. on 08 Dec 2021.

Key facts

This page summarizes Colin Hill's Form 4 filing for PPD, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Dec 2021, 15:41.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$775,675.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PPD transaction

Common Stock

Disposed to Issuer

Transaction value: $775,675
Shares: -16,330
Change %: -100%
Price: $47.50
Shares after: 0
Date: 08 Dec 2021
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Colin Hill is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

On 12/08/2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger").

Footnote F2

Includes 2,164 shares of common stock subject to a restricted stock unit grant (the "RSUs") which provided for vesting on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the Issuer. At the effective time of the Merger, the RSUs were cancelled and converted into the right to receive an amount of cash equal to the Merger Consideration (as defined below) multiplied by the number of restricted stock units being so canceled and converted.

Footnote F3

At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration").